Medical Care
Global Nontuberculous Mycobacterium Treatment Market Research Report 2025
- Jun 28, 25
- ID: 346765
- Pages: 68
- Figures: 69
- Views: 2
The global market for Nontuberculous Mycobacterium Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nontuberculous Mycobacterium Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nontuberculous Mycobacterium Treatment.
The Nontuberculous Mycobacterium Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nontuberculous Mycobacterium Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nontuberculous Mycobacterium Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Insmed Incorporated
RedHill Biopharma
Novoteris
Savara
Beyond Air
Segment by Type
Azithromycin
Rifampin
Rifabutin
Ethambuto
Segment by Application
Hospitals Pharmacies
Private clinics
Drug Stores and Retail Pharmacy
E-commerce
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nontuberculous Mycobacterium Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nontuberculous Mycobacterium Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nontuberculous Mycobacterium Treatment.
The Nontuberculous Mycobacterium Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nontuberculous Mycobacterium Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nontuberculous Mycobacterium Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Insmed Incorporated
RedHill Biopharma
Novoteris
Savara
Beyond Air
Segment by Type
Azithromycin
Rifampin
Rifabutin
Ethambuto
Segment by Application
Hospitals Pharmacies
Private clinics
Drug Stores and Retail Pharmacy
E-commerce
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nontuberculous Mycobacterium Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Azithromycin
1.2.3 Rifampin
1.2.4 Rifabutin
1.2.5 Ethambuto
1.3 Market by Application
1.3.1 Global Nontuberculous Mycobacterium Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals Pharmacies
1.3.3 Private clinics
1.3.4 Drug Stores and Retail Pharmacy
1.3.5 E-commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nontuberculous Mycobacterium Treatment Market Perspective (2020-2031)
2.2 Global Nontuberculous Mycobacterium Treatment Growth Trends by Region
2.2.1 Global Nontuberculous Mycobacterium Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nontuberculous Mycobacterium Treatment Historic Market Size by Region (2020-2025)
2.2.3 Nontuberculous Mycobacterium Treatment Forecasted Market Size by Region (2026-2031)
2.3 Nontuberculous Mycobacterium Treatment Market Dynamics
2.3.1 Nontuberculous Mycobacterium Treatment Industry Trends
2.3.2 Nontuberculous Mycobacterium Treatment Market Drivers
2.3.3 Nontuberculous Mycobacterium Treatment Market Challenges
2.3.4 Nontuberculous Mycobacterium Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nontuberculous Mycobacterium Treatment Players by Revenue
3.1.1 Global Top Nontuberculous Mycobacterium Treatment Players by Revenue (2020-2025)
3.1.2 Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Nontuberculous Mycobacterium Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nontuberculous Mycobacterium Treatment Revenue
3.4 Global Nontuberculous Mycobacterium Treatment Market Concentration Ratio
3.4.1 Global Nontuberculous Mycobacterium Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nontuberculous Mycobacterium Treatment Revenue in 2024
3.5 Global Key Players of Nontuberculous Mycobacterium Treatment Head office and Area Served
3.6 Global Key Players of Nontuberculous Mycobacterium Treatment, Product and Application
3.7 Global Key Players of Nontuberculous Mycobacterium Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nontuberculous Mycobacterium Treatment Breakdown Data by Type
4.1 Global Nontuberculous Mycobacterium Treatment Historic Market Size by Type (2020-2025)
4.2 Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Type (2026-2031)
5 Nontuberculous Mycobacterium Treatment Breakdown Data by Application
5.1 Global Nontuberculous Mycobacterium Treatment Historic Market Size by Application (2020-2025)
5.2 Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nontuberculous Mycobacterium Treatment Market Size (2020-2031)
6.2 North America Nontuberculous Mycobacterium Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025)
6.4 North America Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nontuberculous Mycobacterium Treatment Market Size (2020-2031)
7.2 Europe Nontuberculous Mycobacterium Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025)
7.4 Europe Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size (2020-2031)
8.2 Asia-Pacific Nontuberculous Mycobacterium Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nontuberculous Mycobacterium Treatment Market Size (2020-2031)
9.2 Latin America Nontuberculous Mycobacterium Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025)
9.4 Latin America Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size (2020-2031)
10.2 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Insmed Incorporated
11.1.1 Insmed Incorporated Company Details
11.1.2 Insmed Incorporated Business Overview
11.1.3 Insmed Incorporated Nontuberculous Mycobacterium Treatment Introduction
11.1.4 Insmed Incorporated Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)
11.1.5 Insmed Incorporated Recent Development
11.2 RedHill Biopharma
11.2.1 RedHill Biopharma Company Details
11.2.2 RedHill Biopharma Business Overview
11.2.3 RedHill Biopharma Nontuberculous Mycobacterium Treatment Introduction
11.2.4 RedHill Biopharma Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)
11.2.5 RedHill Biopharma Recent Development
11.3 Novoteris
11.3.1 Novoteris Company Details
11.3.2 Novoteris Business Overview
11.3.3 Novoteris Nontuberculous Mycobacterium Treatment Introduction
11.3.4 Novoteris Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)
11.3.5 Novoteris Recent Development
11.4 Savara
11.4.1 Savara Company Details
11.4.2 Savara Business Overview
11.4.3 Savara Nontuberculous Mycobacterium Treatment Introduction
11.4.4 Savara Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)
11.4.5 Savara Recent Development
11.5 Beyond Air
11.5.1 Beyond Air Company Details
11.5.2 Beyond Air Business Overview
11.5.3 Beyond Air Nontuberculous Mycobacterium Treatment Introduction
11.5.4 Beyond Air Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)
11.5.5 Beyond Air Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Azithromycin
1.2.3 Rifampin
1.2.4 Rifabutin
1.2.5 Ethambuto
1.3 Market by Application
1.3.1 Global Nontuberculous Mycobacterium Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals Pharmacies
1.3.3 Private clinics
1.3.4 Drug Stores and Retail Pharmacy
1.3.5 E-commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nontuberculous Mycobacterium Treatment Market Perspective (2020-2031)
2.2 Global Nontuberculous Mycobacterium Treatment Growth Trends by Region
2.2.1 Global Nontuberculous Mycobacterium Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nontuberculous Mycobacterium Treatment Historic Market Size by Region (2020-2025)
2.2.3 Nontuberculous Mycobacterium Treatment Forecasted Market Size by Region (2026-2031)
2.3 Nontuberculous Mycobacterium Treatment Market Dynamics
2.3.1 Nontuberculous Mycobacterium Treatment Industry Trends
2.3.2 Nontuberculous Mycobacterium Treatment Market Drivers
2.3.3 Nontuberculous Mycobacterium Treatment Market Challenges
2.3.4 Nontuberculous Mycobacterium Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nontuberculous Mycobacterium Treatment Players by Revenue
3.1.1 Global Top Nontuberculous Mycobacterium Treatment Players by Revenue (2020-2025)
3.1.2 Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Nontuberculous Mycobacterium Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nontuberculous Mycobacterium Treatment Revenue
3.4 Global Nontuberculous Mycobacterium Treatment Market Concentration Ratio
3.4.1 Global Nontuberculous Mycobacterium Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nontuberculous Mycobacterium Treatment Revenue in 2024
3.5 Global Key Players of Nontuberculous Mycobacterium Treatment Head office and Area Served
3.6 Global Key Players of Nontuberculous Mycobacterium Treatment, Product and Application
3.7 Global Key Players of Nontuberculous Mycobacterium Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nontuberculous Mycobacterium Treatment Breakdown Data by Type
4.1 Global Nontuberculous Mycobacterium Treatment Historic Market Size by Type (2020-2025)
4.2 Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Type (2026-2031)
5 Nontuberculous Mycobacterium Treatment Breakdown Data by Application
5.1 Global Nontuberculous Mycobacterium Treatment Historic Market Size by Application (2020-2025)
5.2 Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nontuberculous Mycobacterium Treatment Market Size (2020-2031)
6.2 North America Nontuberculous Mycobacterium Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025)
6.4 North America Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nontuberculous Mycobacterium Treatment Market Size (2020-2031)
7.2 Europe Nontuberculous Mycobacterium Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025)
7.4 Europe Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size (2020-2031)
8.2 Asia-Pacific Nontuberculous Mycobacterium Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nontuberculous Mycobacterium Treatment Market Size (2020-2031)
9.2 Latin America Nontuberculous Mycobacterium Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025)
9.4 Latin America Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size (2020-2031)
10.2 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Insmed Incorporated
11.1.1 Insmed Incorporated Company Details
11.1.2 Insmed Incorporated Business Overview
11.1.3 Insmed Incorporated Nontuberculous Mycobacterium Treatment Introduction
11.1.4 Insmed Incorporated Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)
11.1.5 Insmed Incorporated Recent Development
11.2 RedHill Biopharma
11.2.1 RedHill Biopharma Company Details
11.2.2 RedHill Biopharma Business Overview
11.2.3 RedHill Biopharma Nontuberculous Mycobacterium Treatment Introduction
11.2.4 RedHill Biopharma Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)
11.2.5 RedHill Biopharma Recent Development
11.3 Novoteris
11.3.1 Novoteris Company Details
11.3.2 Novoteris Business Overview
11.3.3 Novoteris Nontuberculous Mycobacterium Treatment Introduction
11.3.4 Novoteris Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)
11.3.5 Novoteris Recent Development
11.4 Savara
11.4.1 Savara Company Details
11.4.2 Savara Business Overview
11.4.3 Savara Nontuberculous Mycobacterium Treatment Introduction
11.4.4 Savara Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)
11.4.5 Savara Recent Development
11.5 Beyond Air
11.5.1 Beyond Air Company Details
11.5.2 Beyond Air Business Overview
11.5.3 Beyond Air Nontuberculous Mycobacterium Treatment Introduction
11.5.4 Beyond Air Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)
11.5.5 Beyond Air Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Azithromycin
Table 3. Key Players of Rifampin
Table 4. Key Players of Rifabutin
Table 5. Key Players of Ethambuto
Table 6. Global Nontuberculous Mycobacterium Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Nontuberculous Mycobacterium Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nontuberculous Mycobacterium Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Nontuberculous Mycobacterium Treatment Market Share by Region (2020-2025)
Table 10. Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Nontuberculous Mycobacterium Treatment Market Share by Region (2026-2031)
Table 12. Nontuberculous Mycobacterium Treatment Market Trends
Table 13. Nontuberculous Mycobacterium Treatment Market Drivers
Table 14. Nontuberculous Mycobacterium Treatment Market Challenges
Table 15. Nontuberculous Mycobacterium Treatment Market Restraints
Table 16. Global Nontuberculous Mycobacterium Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Nontuberculous Mycobacterium Treatment Market Share by Players (2020-2025)
Table 18. Global Top Nontuberculous Mycobacterium Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nontuberculous Mycobacterium Treatment as of 2024)
Table 19. Ranking of Global Top Nontuberculous Mycobacterium Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Nontuberculous Mycobacterium Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Nontuberculous Mycobacterium Treatment, Headquarters and Area Served
Table 22. Global Key Players of Nontuberculous Mycobacterium Treatment, Product and Application
Table 23. Global Key Players of Nontuberculous Mycobacterium Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nontuberculous Mycobacterium Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Nontuberculous Mycobacterium Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Insmed Incorporated Company Details
Table 49. Insmed Incorporated Business Overview
Table 50. Insmed Incorporated Nontuberculous Mycobacterium Treatment Product
Table 51. Insmed Incorporated Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)
Table 52. Insmed Incorporated Recent Development
Table 53. RedHill Biopharma Company Details
Table 54. RedHill Biopharma Business Overview
Table 55. RedHill Biopharma Nontuberculous Mycobacterium Treatment Product
Table 56. RedHill Biopharma Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)
Table 57. RedHill Biopharma Recent Development
Table 58. Novoteris Company Details
Table 59. Novoteris Business Overview
Table 60. Novoteris Nontuberculous Mycobacterium Treatment Product
Table 61. Novoteris Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)
Table 62. Novoteris Recent Development
Table 63. Savara Company Details
Table 64. Savara Business Overview
Table 65. Savara Nontuberculous Mycobacterium Treatment Product
Table 66. Savara Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)
Table 67. Savara Recent Development
Table 68. Beyond Air Company Details
Table 69. Beyond Air Business Overview
Table 70. Beyond Air Nontuberculous Mycobacterium Treatment Product
Table 71. Beyond Air Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)
Table 72. Beyond Air Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
Table 76. Authors List of This Report
List of Figures
Figure 1. Nontuberculous Mycobacterium Treatment Picture
Figure 2. Global Nontuberculous Mycobacterium Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nontuberculous Mycobacterium Treatment Market Share by Type: 2024 VS 2031
Figure 4. Azithromycin Features
Figure 5. Rifampin Features
Figure 6. Rifabutin Features
Figure 7. Ethambuto Features
Figure 8. Global Nontuberculous Mycobacterium Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Nontuberculous Mycobacterium Treatment Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Pharmacies Case Studies
Figure 11. Private clinics Case Studies
Figure 12. Drug Stores and Retail Pharmacy Case Studies
Figure 13. E-commerce Case Studies
Figure 14. Nontuberculous Mycobacterium Treatment Report Years Considered
Figure 15. Global Nontuberculous Mycobacterium Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Nontuberculous Mycobacterium Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Nontuberculous Mycobacterium Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Nontuberculous Mycobacterium Treatment Market Share by Players in 2024
Figure 19. Global Top Nontuberculous Mycobacterium Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nontuberculous Mycobacterium Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Nontuberculous Mycobacterium Treatment Revenue in 2024
Figure 21. North America Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Nontuberculous Mycobacterium Treatment Market Share by Country (2020-2031)
Figure 23. United States Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nontuberculous Mycobacterium Treatment Market Share by Country (2020-2031)
Figure 27. Germany Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Share by Region (2020-2031)
Figure 35. China Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nontuberculous Mycobacterium Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Insmed Incorporated Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)
Figure 51. RedHill Biopharma Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)
Figure 52. Novoteris Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)
Figure 53. Savara Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)
Figure 54. Beyond Air Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Azithromycin
Table 3. Key Players of Rifampin
Table 4. Key Players of Rifabutin
Table 5. Key Players of Ethambuto
Table 6. Global Nontuberculous Mycobacterium Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Nontuberculous Mycobacterium Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nontuberculous Mycobacterium Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Nontuberculous Mycobacterium Treatment Market Share by Region (2020-2025)
Table 10. Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Nontuberculous Mycobacterium Treatment Market Share by Region (2026-2031)
Table 12. Nontuberculous Mycobacterium Treatment Market Trends
Table 13. Nontuberculous Mycobacterium Treatment Market Drivers
Table 14. Nontuberculous Mycobacterium Treatment Market Challenges
Table 15. Nontuberculous Mycobacterium Treatment Market Restraints
Table 16. Global Nontuberculous Mycobacterium Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Nontuberculous Mycobacterium Treatment Market Share by Players (2020-2025)
Table 18. Global Top Nontuberculous Mycobacterium Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nontuberculous Mycobacterium Treatment as of 2024)
Table 19. Ranking of Global Top Nontuberculous Mycobacterium Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Nontuberculous Mycobacterium Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Nontuberculous Mycobacterium Treatment, Headquarters and Area Served
Table 22. Global Key Players of Nontuberculous Mycobacterium Treatment, Product and Application
Table 23. Global Key Players of Nontuberculous Mycobacterium Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nontuberculous Mycobacterium Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Nontuberculous Mycobacterium Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Insmed Incorporated Company Details
Table 49. Insmed Incorporated Business Overview
Table 50. Insmed Incorporated Nontuberculous Mycobacterium Treatment Product
Table 51. Insmed Incorporated Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)
Table 52. Insmed Incorporated Recent Development
Table 53. RedHill Biopharma Company Details
Table 54. RedHill Biopharma Business Overview
Table 55. RedHill Biopharma Nontuberculous Mycobacterium Treatment Product
Table 56. RedHill Biopharma Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)
Table 57. RedHill Biopharma Recent Development
Table 58. Novoteris Company Details
Table 59. Novoteris Business Overview
Table 60. Novoteris Nontuberculous Mycobacterium Treatment Product
Table 61. Novoteris Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)
Table 62. Novoteris Recent Development
Table 63. Savara Company Details
Table 64. Savara Business Overview
Table 65. Savara Nontuberculous Mycobacterium Treatment Product
Table 66. Savara Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)
Table 67. Savara Recent Development
Table 68. Beyond Air Company Details
Table 69. Beyond Air Business Overview
Table 70. Beyond Air Nontuberculous Mycobacterium Treatment Product
Table 71. Beyond Air Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)
Table 72. Beyond Air Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
Table 76. Authors List of This Report
List of Figures
Figure 1. Nontuberculous Mycobacterium Treatment Picture
Figure 2. Global Nontuberculous Mycobacterium Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nontuberculous Mycobacterium Treatment Market Share by Type: 2024 VS 2031
Figure 4. Azithromycin Features
Figure 5. Rifampin Features
Figure 6. Rifabutin Features
Figure 7. Ethambuto Features
Figure 8. Global Nontuberculous Mycobacterium Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Nontuberculous Mycobacterium Treatment Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Pharmacies Case Studies
Figure 11. Private clinics Case Studies
Figure 12. Drug Stores and Retail Pharmacy Case Studies
Figure 13. E-commerce Case Studies
Figure 14. Nontuberculous Mycobacterium Treatment Report Years Considered
Figure 15. Global Nontuberculous Mycobacterium Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Nontuberculous Mycobacterium Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Nontuberculous Mycobacterium Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Nontuberculous Mycobacterium Treatment Market Share by Players in 2024
Figure 19. Global Top Nontuberculous Mycobacterium Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nontuberculous Mycobacterium Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Nontuberculous Mycobacterium Treatment Revenue in 2024
Figure 21. North America Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Nontuberculous Mycobacterium Treatment Market Share by Country (2020-2031)
Figure 23. United States Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nontuberculous Mycobacterium Treatment Market Share by Country (2020-2031)
Figure 27. Germany Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Share by Region (2020-2031)
Figure 35. China Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nontuberculous Mycobacterium Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Insmed Incorporated Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)
Figure 51. RedHill Biopharma Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)
Figure 52. Novoteris Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)
Figure 53. Savara Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)
Figure 54. Beyond Air Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232